Biologics4Life Technology Provides New Clinical Option for Osteoporotic Patients

Biologics4Life has developed Neo-S, a patent-pending technology. Neo-S bone graft substitute is combined with an active principle to form an advanced biomaterial which addresses the needs of patients with osteoporosis or bone metastasis. This patent will strengthen the company’s intellectual property portfolio and is a major step in the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us